The utility of body FDG PET in staging primary central nervous system lymphoma
about
A systematic approach to the diagnosis of suspected central nervous system lymphoma.18F-FDG PET in the diagnosis and treatment of primary central nervous system lymphoma.Disseminated encephalomyelitis-like central nervous system neoplasm in childhood.Advances in Primary Central Nervous System Lymphoma.[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma.Progress in central nervous system lymphomas.Primary diffuse large B-cell lymphoma of the central nervous system: A case report and literature reviewBrain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma.New approaches in primary central nervous system lymphoma.How I treat CNS lymphomas.Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful.Primary low-grade diffuse small lymphocytic lymphoma of the central nervous system.Pathogenesis and management of primary CNS lymphoma.Current role of FDG PET/CT in lymphoma.Unusual relapse of primary central nervous system lymphoma.The Challenge of Primary Central Nervous System Lymphoma.Cerebral Toxoplasmosis in a Patient with AIDS on F-18 FDG PET/CT.A new diagnostic marker for differentiating multicentric gliomas from multiple intracranial diffuse large B-cell lymphomas on 18F-FDG PET images.Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series.18F-FDG PET/CT in primary brain lymphoma.Diagnosis and management of primary central nervous system lymphoma.Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patients.Primary central nervous system lymphoma
P2860
Q30586022-2596B6C8-ACD7-4720-8573-F7B19210E215Q30654615-351B5732-3B1B-4102-9E18-C701F7A722CDQ30656415-3D5B60CC-8601-4297-802F-A0D6BFEB52F1Q31007237-D4CC2F25-6622-4CC1-918B-230C6FD65F66Q33395877-B6D3A4BF-6827-4E3E-9F0E-81D9FF4C74E6Q33934406-1E943F56-49CD-410B-8054-5DE2751F4C50Q36825261-37FA352A-BD6A-4367-8F48-494262B2C77EQ36951072-95CC3968-94AF-4952-801F-07F191B21CCDQ37088471-ABBB4997-5042-45E5-8FE4-5BFF16003DD6Q37215118-4CB5F084-A405-4FC3-A3CF-B25CE23C4DC4Q37589543-690F87B5-1974-4686-8762-D33B49571BCCQ37703600-BC43863A-2425-4DF4-9CF9-ABDD5F40A9A4Q38010799-9675AE8F-4F23-42FB-B5B3-F9140A21FEC9Q38187365-DDDFA56E-7A1B-4FE5-8374-59C7A885404BQ38850335-15EE97FB-F091-4F6D-8B9E-1516B850B633Q39020652-82A4D42A-F072-45FD-B8F4-4C8CC2334BD9Q40218220-19DC49D8-1912-4808-93CB-50BA6816162FQ41390493-C8943368-E9ED-4C6F-B402-F3EC987B166CQ44981700-9830B551-ED19-4CE7-9492-A00D84D5AC6AQ47576872-3EE47151-98E9-448B-A100-5E7316C4C01FQ48095976-347FBF7B-0EB0-48B8-A236-95030DFBA025Q55402302-E9F00BC4-003B-4139-81C3-6AD49636F1B3Q57297768-62EA6863-187E-4CE0-A83A-30DEF31E98FF
P2860
The utility of body FDG PET in staging primary central nervous system lymphoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The utility of body FDG PET in staging primary central nervous system lymphoma
@en
The utility of body FDG PET in staging primary central nervous system lymphoma.
@nl
type
label
The utility of body FDG PET in staging primary central nervous system lymphoma
@en
The utility of body FDG PET in staging primary central nervous system lymphoma.
@nl
prefLabel
The utility of body FDG PET in staging primary central nervous system lymphoma
@en
The utility of body FDG PET in staging primary central nervous system lymphoma.
@nl
P2093
P2860
P1433
P1476
The utility of body FDG PET in staging primary central nervous system lymphoma
@en
P2093
Lauren E Abrey
Lisa M Deangelis
Nimish A Mohile
P2860
P304
P356
10.1215/15228517-2007-061
P577
2008-02-20T00:00:00Z